Aegex Launches European Distribution Channel with ScanSource
8.5.2017 10:00 | NASDAQ OMX
ScanSource representatives will supply Aegex products, including the Aegex10 Intrinsically Safe Tablet and the Aegex IoT Platform for Hazardous Locations, to existing Aegex resellers in the region. In addition, ScanSource provides pre- and post-sale support, education and training, marketing support and enablement tools so that resellers can focus on sales and customer service.
ScanSource will host a series of networking events from May through December 2017, called ScanSource Live, at which resellers can learn more about the solutions ScanSource offers, including Aegex products. Potential events are scheduled as follows (subject to change):
DACH: 11 & 12 May 2017 - Frankfurt area, Germany
South: 1 & 2 June 2017 - Barcelona area, Spain
UK: 18 & 19 September 2017 - Midlands, UK
Benelux: 13 September 2017 - Antwerp, Belgium
Eastern Europe: 12 & 13 October 2017, Warsaw, Poland
Nordics: 26 & 27 October 2017 - Malmo, Sweden or Copenhagen, Denmark
ScanSource will also offer Aegex products through a variety of online channels, including the ScanSource website, ScanSource e-catalogue, ScanSource Showpad app and PartnerPAD managed tablet solution.
Contact ScanSource Europe for additional information about the Aegex partnership.
With world headquarters in Atlanta, Ga., USA, European headquarters in Rotterdam, Netherlands, sales offices in Southampton, UK and Dubai, UAE, and distributors worldwide, Aegex is the maker of the first globally certified intrinsically safe Windows 10 tablet and the first dedicated IoT Platform for Hazardous Locations.
The Aegex10 Intrinsically Safe Tablet is certified for IECEx Zone 1, ATEX Zone 1, UL Class I, II, III Division 1, and CSA 22.2 hazardous areas. With rugged IP65 rating and weighing just 980 grams, the Aegex tablet is priced as low as non-certified devices for immediate ROI. Its Windows 10 OS assures easy synchronization with existing IT systems.
With 4G LTE or WI-Fi connectivity Aegex tablet users can manage real-time Internet of Things data from within the most hazardous zones of their operations. Along with Aegex IoT sensors, analytics, and UI, the Aegex IoT Platform for Hazardous Locations provides cloud-based connectivity that improves safety, efficiency and compliance and lowers risk, resulting in decreased downtime and optimized operations.
Watch the latest Aegex video to learn more.
Aegex Technologies, LLC
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Aegex Technologies via Globenewswire
Följ NASDAQ OMX
Skriv in din e-postadress så får du ett mejl när vi har något nytt att berätta.
Senaste nyheterna från NASDAQ OMX
Nasdaq Closing Cross Calculates Russell US Indexes Reconstitution for the 14th Consecutive Year24.6.2017 01:52 | Pressmeddelande
A new record $28.9 billion traded at the closing cross in a Russell reconstitution NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- Nasdaq (Symbol: NDAQ) today announced the Nasdaq Closing Cross was used for the 14th consecutive year to rebalance Nasdaq-listed securities in the entire family of Russell US Indexes, part of leading global index provider FTSE Russell, during its annual reconstitution. More than 972 million shares representing a record $28.9 billion were executed in the Nasdaq Closing Cross in 0.861 seconds across some 2,499 Nasdaq-listed stocks. The previous record for dollars traded at the closing cross in a Russell reconstitution was $21.1 billion in 2015. "For the 14th consecutive year of partnering with FTSE Russell on the rebalance, we witnessed the advanced capabilities and market integrity of Nasdaq's INET technology platform resulting in transparent and efficient price discovery which benefits issuers and investors alike,"
LifeSci Advisors' Board Placement Initiative Announces Ninth Board Placement23.6.2017 17:52 | Pressmeddelande
NEW YORK, June 23, 2017 (GLOBE NEWSWIRE) -- LifeSci Advisors, a leading life sciences-focused investor relations consultancy, announced today the ninth placement of a female executive to a life sciences company board as part of their Board Placement Initiative (BPI), a program launched a year ago with the goal to connect female executives in the life sciences industry with companies looking for board candidates. LifeSci is pleased to share news of the appointment of Jean M. Franchi to the Board of Directors of Biophytis, a biotech company listed on Euronext Paris (ALBPS) focused on drugs that target diseases of aging, with drug candidates in clinical development for dry AMD and Sarcopenia. "I'm honored to join the Biophytis board, and look forward to helping the company achieve a more global presence as it advances its portfolio of innovative therapies addressing unmet needs associated with aging," said Ms. Franchi. "I want to extend my kind thanks to LifeSci
Fentress Architects Announces its Annual Student Global Challenge23.6.2017 09:00 | Pressmeddelande
6th edition invites students to re-envision the terminal building in the year 2075 Denver, Colorado, June 23, 2017 (GLOBE NEWSWIRE) -- Fentress Architects, based in Denver, Colorado, announces the 2017 Fentress Global Challenge, an international design competition for young and student architects. As in years past, the theme, consistent with the firm's expertise in airport design and aviation, is envisioning an airport of the future. Participants are encouraged to re-envision the terminal building in the year 2075 using one of 10 existing international airports, taking into consideration local context, technological trends, and project feasibility and passenger experience. This is the sixth year that Fentress Architects has sponsored and administered the award, which brings a First Prize of $15,000 and a summer internship at Fentress' Denver office; four additional winners will receive smaller cash awards.
Oxford Immunotec Announces National Reimbursement for the T-SPOT®.TB Test in France22.6.2017 22:50 | Pressmeddelande
OXFORD, United Kingdom and MARLBOROUGH, Mass., June 22, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced a decision from the French Ministry of Health and Social Affairs to reimburse interferon gamma release assays, or IGRAs, for latent TB screening in at risk patient populations. Upon implementation of the new reimbursement codes, which is expected in the next 21 days, the French Ministry of Health and Social Affairs will provide reimbursement for the T-SPOT. TB test at a rate of approximately 60 Euros per test. About Oxford Immunotec Oxford Immunotec Global PLC is a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-r
Standard Lithium Raises $7.4 Million in Oversubscribed Financing22.6.2017 21:49 | Pressmeddelande
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 22, 2017 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. ("Standard Lithium" or the "Company") (TSXV:SLL) (FRA:S5L) is pleased to announce that it has completed the private placement of 9,894,785 common shares at a price of $0.75 per share for gross proceeds of $7,421,089. Interest in the placement far exceeded the expectations of the Company, and the additional amount raised provides the Company with the capital needed to advance its current projects and pursue strategic acquisitions in the lithium sector. "We are extremely pleased with the interest received in this placement, and completion represents a significant milestone for the Company," commented Anthony Alvaro, a director of the Company. "The strong demand speaks to the growing confidence in our team, projects and futur
IAGC: Plankton Study Speculative and Needs Better Data22.6.2017 16:08 | Pressmeddelande
Houston, TX, US, June 22, 2017 (GLOBE NEWSWIRE) -- The International Association of Geophysical Contractors (IAGC) released the following statement regarding the publishing of research on the interaction of seismic surveys and zooplankton in Nature: Ecology and Evolution. The IAGC President, Nikki Martin issued the following statement: "While we found the study interesting, we are also troubled by the small sample sizes, the large day-to-day variability in both the baseline and experimental data, and the large number of speculative conclusions that appear inconsistent with the data collected over a two-day period. Both statistically and methodologically, this project falls short of what would be needed to provide a convincing case for adverse effects from geophysical survey operations. "Although the initial report is peer-reviewed, it has not been widely accepted by the expert scientific community. We look forward to discussing this topic further with
I vårt nyhetsrum kan du läsa de senaste nyheterna, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt nyhetsrum